These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Dopamine D2-Subtype Receptors Outside the Blood-Brain Barrier Mediate Enhancement of Mesolimbic Dopamine Release and Conditioned Place Preference by Intravenous Dopamine. Obray JD; Small CA; Baldwin EK; Jang EY; Lee JG; Yang CH; Yorgason JT; Steffensen SC Front Cell Neurosci; 2022; 16():944243. PubMed ID: 35903367 [TBL] [Abstract][Full Text] [Related]
49. Understanding the role of dopamine in cancer: past, present and future. Grant CE; Flis AL; Ryan BM Carcinogenesis; 2022 Jun; 43(6):517-527. PubMed ID: 35616105 [TBL] [Abstract][Full Text] [Related]
50. Receptor-Mediated AKT/PI3K Signalling and Behavioural Alterations in Zebrafish Larvae Reveal Association between Schizophrenia and Opioid Use Disorder. Thiagarajan SK; Mok SY; Ogawa S; Parhar IS; Tang PY Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563106 [TBL] [Abstract][Full Text] [Related]
51. The organic cation transporter 2 regulates dopamine D1 receptor signaling at the Golgi apparatus. Puri NM; Romano GR; Lin TY; Mai QN; Irannejad R Elife; 2022 Apr; 11():. PubMed ID: 35467530 [TBL] [Abstract][Full Text] [Related]
52. Class A and C GPCR Dimers in Neurodegenerative Diseases. Caniceiro AB; Bueschbell B; Schiedel AC; Moreira IS Curr Neuropharmacol; 2022; 20(11):2081-2141. PubMed ID: 35339177 [TBL] [Abstract][Full Text] [Related]
53. The Aversion Function of the Limbic Dopaminergic Neurons and Their Roles in Functional Neurological Disorders. He Z; Jiang Y; Gu S; Wu D; Qin D; Feng G; Ma X; Huang JH; Wang F Front Cell Dev Biol; 2021; 9():713762. PubMed ID: 34616730 [TBL] [Abstract][Full Text] [Related]
54. The role of dopamine receptors in lymphocytes and their changes in schizophrenia. Penedo MA; Rivera-Baltanás T; Pérez-Rodríguez D; Allen J; Borrajo A; Alonso-Crespo D; Fernández-Pereira C; Nieto-Araujo M; Ramos-García S; Barreiro-Villar C; Caruncho HJ; Olivares JM; Agís-Balboa RC Brain Behav Immun Health; 2021 Mar; 12():100199. PubMed ID: 34589732 [TBL] [Abstract][Full Text] [Related]
55. History of the dopamine hypothesis of antipsychotic action. Seeman MV World J Psychiatry; 2021 Jul; 11(7):355-364. PubMed ID: 34327128 [TBL] [Abstract][Full Text] [Related]
56. Ligand recognition and allosteric regulation of DRD1-Gs signaling complexes. Xiao P; Yan W; Gou L; Zhong YN; Kong L; Wu C; Wen X; Yuan Y; Cao S; Qu C; Yang X; Yang CC; Xia A; Hu Z; Zhang Q; He YH; Zhang DL; Zhang C; Hou GH; Liu H; Zhu L; Fu P; Yang S; Rosenbaum DM; Sun JP; Du Y; Zhang L; Yu X; Shao Z Cell; 2021 Feb; 184(4):943-956.e18. PubMed ID: 33571432 [TBL] [Abstract][Full Text] [Related]
57. Structure of the dopamine D Im D; Inoue A; Fujiwara T; Nakane T; Yamanaka Y; Uemura T; Mori C; Shiimura Y; Kimura KT; Asada H; Nomura N; Tanaka T; Yamashita A; Nango E; Tono K; Kadji FMN; Aoki J; Iwata S; Shimamura T Nat Commun; 2020 Dec; 11(1):6442. PubMed ID: 33353947 [TBL] [Abstract][Full Text] [Related]
58. A Split Luciferase Complementation Assay for the Quantification of β-Arrestin2 Recruitment to Dopamine D Forster L; Grätz L; Mönnich D; Bernhardt G; Pockes S Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847148 [TBL] [Abstract][Full Text] [Related]
59. The Response of Ventral Tegmental Area Dopaminergic Neurons to Bupropion: Excitation or Inhibition? Sadighparvar S; Tale F; Shahabi P; Naderi S; Ghaderi Pakdel F Basic Clin Neurosci; 2019; 10(4):281-304. PubMed ID: 32231766 [TBL] [Abstract][Full Text] [Related]